企業プロフィール
Nemaura Medical 株価・ニュース・カタリスト
- ティッカー:
- NMRD
- 取引所:
- PINK
- セクター:
- Biopharma
- 所在地:
- United Kingdom and trades in the U
株価パフォーマンス
0.00 USD (0.00%)
終値
最終更新: 2026年10月1日
—
時価総額
株価変動の要因
NMRD の終値変動に関する情報は現在取得できません。
企業概要
Non-Invasive Glucose Monitoring Company
Nemaura Medical develops wearable systems intended to measure glucose without penetrating the skin. Its platform is designed for metabolic health, diabetes management, and behavior-change programs.
SugarBEAT Sensor Platform
SugarBEAT uses a small skin-worn sensor and transmitter to collect glucose readings from interstitial fluid. Data are displayed through a mobile application to show glucose patterns and trends throughout the day.
proBEAT Metabolic Program
proBEAT combines glucose data with coaching and digital tools for people with type 2 diabetes or elevated metabolic risk. The service is intended to help users understand how food, activity, and lifestyle affect glucose response.
Device and Subscription Economics
Potential revenue sources include reusable transmitters, disposable sensors, software, coaching subscriptions, and partnerships with healthcare or wellness organizations. Regulatory clearance and reimbursement are important to broader clinical adoption.
今後のカタリスト
最近のニュース
ニュースタイトルは機械翻訳です。詳細は英語の原文をご覧ください。
- 01
- 02
- 03
- 04
- 05
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。